Watchlist Price Alert

Anavex Life Sciences Corp... (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

8.32

-0.05 (-0.60%)

At close: May 16, 2025, 3:59 PM

8.32

0.00%

After-hours: May 16, 2025, 05:32 PM EDT

Anavex Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cash & Equivalents	132.19M	151.02M	149.16M	152.11M	29.25M	22.19M	22.93M	27.44M	9.19M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	16.36K	n/a	n/a	52.4K	52.4K	52.4K
Receivables	2.45M	2.71M	3.19M	9.14M	4.85M	2.64M	1.87M	9.75K	79.35K
Inventory	n/a	n/a	n/a	16.36K	n/a	-2.64M	n/a	n/a	n/a
Other Current Assets	931K	653K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	135.57M	154.39M	152.7M	161.62M	34.54M	25.33M	24.32M	27.79M	9.45M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	16.36K	n/a	n/a	52.4K	52.4K	52.4K
Total Assets	135.57M	154.39M	152.7M	161.62M	34.54M	25.33M	24.38M	27.84M	9.5M
Account Payables	9.63M	4.32M	3.82M	4.74M	3.99M	3.52M	2.96M	3.58M	3.06M
Deferred Revenue	842K	n/a	443.83K	443.83K	n/a	n/a	n/a	n/a	70.53K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.53M	6.85M	5.09M	n/a	n/a	n/a	n/a	n/a	70.53K
Total Current Liabilities	15.3M	12.53M	10.21M	10.8M	7.31M	5.04M	3.88M	3.58M	3.19M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	4.83M	n/a	4.27M	5.61M	3.32M	1.52M	n/a	n/a	n/a
Total Liabilities	15.3M	12.53M	10.21M	10.8M	7.31M	5.04M	3.88M	3.58M	3.19M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	85K	82K	77.94K	75.92K	62.05K	52.65K	45.94K	43.33K	36.17K
Retained Earnings	-336.07M	-293.07M	-245.56M	-197.59M	-159.68M	-133.4M	-108.93M	-91.48M	-78.02M
Comprehensive Income	n/a	0.00	0.00	-0.00	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	120.26M	141.85M	142.49M	150.82M	27.24M	20.29M	20.49M	24.25M	6.31M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a